Literature DB >> 21427116

Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.

M Hudecova1, J Holte, M Olovsson, A Larsson, C Berne, I Sundström Poromaa.   

Abstract

BACKGROUND: The overall risk of developing diabetes mellitus and glucose intolerance seems to be higher in women with polycystic ovary syndrome (PCOS) than in healthy women. The aim of this long-term follow-up study was to examine glucose tolerance and insulin sensitivity in middle-aged women previously diagnosed with PCOS in comparison with age-matched healthy controls.
METHODS: Women diagnosed with PCOS between 1987 and 1995 were invited to participate in the study. A total of 84 PCOS patients and 87 control subjects participated. Anthropometric (BMI, waist/hip ratio) and metabolic parameters (oral glucose tolerance test) were measured. Insulin sensitivity was expressed by the Matsuda index and beta cell function by the insulinogenic index. PCOS women were subgrouped according to phenotype at the index assessment (with or without hyperandrogenism) and persistence of PCOS symptoms at the follow-up (persisting or resolved PCOS).
RESULTS: Eighteen (21.4%) PCOS patients and four (4.5%) controls had developed type 1 or type 2 diabetes or impaired glucose tolerance (IGT) at the follow-up investigation (P < 0.05). Matsuda insulin sensitivity index was lower and the insulinogenic index was increased in women with previously diagnosed PCOS compared with control subjects. In addition, PCOS patients with or without hyperandrogenism, and PCOS patients with persisting and resolved PCOS all had lower Matsuda insulin sensitivity index and increased insulinogenic index in comparison with controls.
CONCLUSIONS: IGT and type 2 diabetes occurred more often in PCOS patients. Independent on PCOS phenotype at index assessment and persistence of PCOS symptoms at the follow-up investigation, women with PCOS had lower insulin sensitivity but a well-preserved beta cell function in comparison with control subjects.

Entities:  

Mesh:

Year:  2011        PMID: 21427116     DOI: 10.1093/humrep/der065

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

1.  Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.

Authors:  Panagiotis Anagnostis; Rodis D Paparodis; Julia K Bosdou; Christina Bothou; Djuro Macut; Dimitrios G Goulis; Sarantis Livadas
Journal:  Endocrine       Date:  2021-06-26       Impact factor: 3.633

2.  Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.

Authors:  Jenny L Wilson; Weiyi Chen; Gregory A Dissen; Sergio R Ojeda; Michael A Cowley; Cecilia Garcia-Rudaz; Pablo J Enriori
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

Review 3.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

4.  Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.

Authors:  M M Ollila; S West; S Keinänen-Kiukaanniemi; J Jokelainen; J Auvinen; K Puukka; A Ruokonen; M-R Järvelin; J S Tapanainen; S Franks; T T Piltonen; L C Morin-Papunen
Journal:  Hum Reprod       Date:  2016-12-28       Impact factor: 6.918

Review 5.  A Review on the Assessment of the Efficacy of Common Treatments in Polycystic Ovarian Syndrome on Prevention of Diabetes Mellitus.

Authors:  Sareh Dashti; Latiffah Abdul Latiff; Nor Afiah Binti Mohd Zulkefli; Anisah Binti Baharom; Halimatus Sakdiah Minhat; Habibah Abdul Hamid; Maimunah Ismail; Ali Jafarzadeh Esfehani; Azrin Shah Abu Bakar; Nur Amirah Inani Binti Sabri
Journal:  J Family Reprod Health       Date:  2017-06

Review 6.  Markers of insulin resistance in Polycystic ovary syndrome women: An update.

Authors:  Chantal Anifa Amisi
Journal:  World J Diabetes       Date:  2022-03-15

7.  Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome.

Authors:  Xiaohui Xu; Yerui Lai; Gangyi Yang; Mengliu Yang; Ling Li; Qin Zhang; Hua Liu; Hongting Zheng; Danping Zhu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

8.  Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels.

Authors:  Andi Li; Lu Zhang; Jiajia Jiang; Nan Yang; Ying Liu; Lingbo Cai; Yugui Cui; Feiyang Diao; Xiao Han; Jiayin Liu; Yujie Sun
Journal:  J Biomed Res       Date:  2017-11-01

9.  Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.

Authors:  V Wekker; L van Dammen; A Koning; K Y Heida; R C Painter; J Limpens; J S E Laven; J E Roeters van Lennep; T J Roseboom; A Hoek
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

10.  An overview of polycystic ovary syndrome in aging women

Authors:  Özlem Çelik; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2021-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.